Status: Recruiting
Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
The SCORE-NHL study is a prospective, multi-center, study designed to collect data and biological samples from participants diagnosed with aggressive Stage I to IV non-Hodgkin Lymphoma (NHL). Study participants will undergo research blood collections of up to 60 mL as well as residual tissue collection, collected as part of a standard of care procedure, for use in research. Collected samples and data will be analyzed to evaluate biomarkers associated with development and validation of cancer monitoring and detection assays ("Natera cancer monitoring and detection test(s)").
Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Natera, Inc.Updated: Aug 6, 2026Locations: 1
Eligibility criteria
Patient is at least 18 years of age or older. [+6]
Diagnosis of an indolent lymphoma that does not require immediate intervention,... [+5]